Fig. 1From: Engineering anti-Lewis-Y hu3S193 antibodies with improved therapeutic ratio for radioimmunotherapy of epithelial cancersBiodistribution with 131I- (a, c and e) and 111In-CHX-A″ DTPA-labelled (b, d and f) hu3S193 antibodies. n = 5; bars, SDBack to article page